Skip to main
MODV
MODV logo

ModivCare (MODV) Stock Forecast & Price Target

ModivCare (MODV) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

ModivCare's stock outlook is positively influenced by an increase in utilization of non-emergency medical transportation (NEMT) services, which rose by 192 basis points to 10.8%, demonstrating strong demand in its primary revenue segment. The personal care services (PCS) segment also showed resilience, with a 3.0% growth in top-line service revenue driven by a 3.5% increase in revenue per hour, despite a slight decline in total hours worked. Additionally, the company reported an adjusted EBITDA margin of 9.4%, reflecting operational efficiency improvements and indicating ongoing strategic efforts to enhance financial stability and capture savings through increased fee-for-service contracting.

Bears say

ModivCare's adjusted EBITDA for the RPM segment fell below expectations at $6.8 million, reflecting softer margins at approximately 35.4%. The NEMT business is projected to face a top-line decline of about 6.7% in 2025, primarily due to a $200 million net revenue headwind from significant contract losses. Additionally, the company reported a 0.8% decline in NEMT segment revenue for the latest quarter, compounded by a approximately 600-basis point decrease in operating margins to just over 3% in FY/24.

ModivCare (MODV) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ModivCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ModivCare (MODV) Forecast

Analysts have given ModivCare (MODV) a Buy based on their latest research and market trends.

According to 5 analysts, ModivCare (MODV) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ModivCare (MODV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.